Cargando…

Under-representation of key demographic groups in opioid use disorder trials

BACKGROUND: The extent to which clinical trials of medications for opioid use disorder (MOUD) are representative or not is unknown. Some patient characteristics modify MOUD effectiveness; if these same characteristics differ in distribution between the trial population and usual-care population, thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rudolph, Kara E., Russell, Matthew, Luo, Sean X., Rotrosen, John, Nunes, Edward V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Full Length Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524855/ https://www.ncbi.nlm.nih.gov/pubmed/36187300 http://dx.doi.org/10.1016/j.dadr.2022.100084

Ejemplares similares

Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment
por: Pan, Yue, et al.
Publicado: (2022)

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder
por: Hefner, Kathryn, et al.
Publicado: (2022)

Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder
por: Scherrer, Jeffrey F., et al.
Publicado: (2022)

Demographic and psychiatric correlates of compulsive sexual behaviors in gambling disorder
por: Cowie, Megan E., et al.
Publicado: (2019)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

DSM-5 criteria for gambling disorder: Underlying structure and applicability to specific groups of gamblers
por: Sleczka, Pawel, et al.
Publicado: (2015)

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
por: Xu, Kevin Y, et al.
Publicado: (2023)

Negative attitudes about medications for opioid use disorder among criminal legal staff
por: Moore, Kelly E., et al.
Publicado: (2022)

Medicaid expansion and opioid supply policies to address the opioid overdose crisis
por: Shakya, Shishir, et al.
Publicado: (2022)

The association between medication for opioid use disorder and employment outcomes in the U.S.: The relevance of race and ethnicity
por: Hoang, Bai Linh, et al.
Publicado: (2022)

Critical access medication for opioid use disorder (MOUD) treatment facilities in the continental United States
por: Pollack, Harold A., et al.
Publicado: (2022)

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
por: Shadowen, Hannah, et al.
Publicado: (2022)

Residential treatment and medication treatment for opioid use disorder: The role of state Medicaid innovations in advancing the field
por: O'Brien, Peggy L., et al.
Publicado: (2022)

A qualitative exploration of the eight dimensions of wellness in opioid use disorder recovery during the postpartum period
por: Mallahan, Stephanie, et al.
Publicado: (2023)

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV
por: Parchinski, Kaley, et al.
Publicado: (2023)

Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service
por: Nordeck, Courtney D., et al.
Publicado: (2022)

Peer recovery coaching for comprehensive HIV, hepatitis C, and opioid use disorder management: The CHORUS pilot study
por: Martin, Anna K., et al.
Publicado: (2023)

Similar COVID-19 incidence to the general population in people with opioid use disorder receiving integrated outpatient clinical care
por: Vallecillo, Gabriel, et al.
Publicado: (2022)

Listening to women and pregnant and postpartum people: Qualitative research to inform opioid use disorder treatment for pregnant and postpartum people
por: Guille, Constance, et al.
Publicado: (2022)

Opportunities to expand postpartum support for those in recovery from opioid use disorder: Results from a qualitative study
por: Allen, Alicia, et al.
Publicado: (2023)

Qualitative exploration of public health vending machines in young adults who misuse opioids: A promising strategy to increase naloxone access in a high risk underserved population
por: Wagner, Nicole M., et al.
Publicado: (2022)

Validation and endorsement of health system performance measures for opioid use disorder in British Columbia, Canada: A Delphi panel study
por: Kamran, Hasham, et al.
Publicado: (2022)

Identifying mortality risks in patients with opioid use disorder using brief screening assessment: Secondary mental health clinical records analysis
por: Bogdanowicz, Karolina Magda, et al.
Publicado: (2016)

Inhibitory Potential of Acroptilon repens against Key Enzymes involved in Alzheimer and Diabetes, Phytochemical Profile, Radical Scavenging, and Antibacterial Activity
por: Afsharnezhad, Moslem, et al.
Publicado: (2021)

Demographic factors that impact attitudes toward medical cannabis
por: Clobes, Thomas A., et al.
Publicado: (2022)

Analysis of NSP4 Gene and Its Association with Genotyping of Rotavirus Group A in Stool Samples
por: Teimoori, Ali, et al.
Publicado: (2018)

What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size
por: Keyes, Katherine M., et al.
Publicado: (2022)

Shielding working-memory representations from temporally predictable external interference
por: Gresch, Daniela, et al.
Publicado: (2021)

Blended transdiagnostic group CBT for emotional disorders: A feasibility trial protocol
por: Díaz-García, Amanda, et al.
Publicado: (2021)

Parenting and childcare responsibilities, harm reduction service engagement, and opioid overdose among women and men who use illicit opioids in New York City
por: Scheidell, Joy D, et al.
Publicado: (2022)

Association of chronic non-cancer pain status and buprenorphine treatment retention among individuals with opioid use disorder: Results from electronic health record data
por: John, William S., et al.
Publicado: (2022)

The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City()
por: Morgan, Jake R., et al.
Publicado: (2022)

Treatment outcomes of a CBT-based group intervention for adolescents with Internet use disorders
por: Szász-Janocha, Carolin, et al.
Publicado: (2020)

Activation of Toll-Like Receptors 2 by High-Mobility Group Box 1 in Monocytes from Patients with Ischemic Stroke
por: Sadat-Hatamnezhad, Leila, et al.
Publicado: (2016)

COVID-19 impact on opioid overdose after jail release in Massachusetts
por: Friedmann, Peter D., et al.
Publicado: (2023)

Development of Streptococcus equisimilis Group G Mutant Strains with Ability to Produce Low Polydisperse and Low-Molecular-Weight Hyaluronic Acid
por: Jafari, Bahareh, et al.
Publicado: (2022)

Omnidirectional 2.5D representation for COVID-19 diagnosis using chest CTs()
por: da Silveira, Thiago L.T., et al.
Publicado: (2023)

Associations among the opioid receptor gene (OPRM1) A118G polymorphism, psychiatric symptoms, and quantitative EEG in Korean males with gambling disorder: A pilot study
por: Kim, Kyoung Min, et al.
Publicado: (2019)

Group B streptococcal disease in the mother and newborn—A review
por: Steer, Philip J., et al.
Publicado: (2020)

Differential expression of NPAS4 in the dorsolateral prefrontal cortex following opioid overdose
por: Sosnowski, David W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bg47kdhdht8d3fg11ro70u3noj